Skip to content
Medical Health Aged Care

De-escalation VR training for behavioural emergencies set to revolutionise dementia education – on show today at Melbourne Convention and Exhibition Centre

Dementia Australia 3 mins read

In Melbourne today Dementia Australia will unveil D-Esc, a new innovative virtual reality (VR) training workshop for de-escalating a behavioural emergency in a care setting.   

D-Esc provides an immersive simulation, designed for frontline and health care professionals, to adopt an interactive approach to de-escalation training. Participants will build empathy and understanding towards people with dementia, with the aim to reduce the use of restrictive practices and the number and severity of dangerous incidents in care.

Dementia Australia Executive Director Services, Advocacy and Research Dr Kaele Stokes said this new workshop provides training which is integral to the safety and professional development of the workforce and to improving the care of people living with dementia.

“Behavioural emergencies and occupational violence in aged care are time-critical emergencies,” said Dr Stokes.

“We know that dementia can change people’s behaviour. People living with dementia may feel anxious, fearful, distressed, confused. They may also be in pain or disorientated.

“Sometimes the way they are experiencing a situation may mean a person is unable to communicate how they feel or what they are experiencing in the familiar ways.

“Additionally, the way a care worker communicates with people living with dementia is vital. Communication is not just talking.

“Gestures, movement and facial expressions can all convey meaning. Body language and physical contact become significant when speech is difficult for a person with dementia.

“Course participants will build their empathy, increase their understanding of dementia and skills in communication, recognising emotional and physical signs of escalation and how to reduce the risk of harm for both the person with dementia, other residents, visitors and staff.

“D-Esc leverages technology to build participants’ confidence and capability to assess and respond effectively to changed behaviours safely.”

Dementia Australia Dementia Advocate Phil Hazell lives with younger onset dementia. Mr Hazell believes that training like this is important for promoting understanding and awareness around dementia.

“I like to know that I am understood. It is important that people comprehend what dementia is and how it can affect people differently,” said Mr Hazell.

“Training can help workers to understand, approach and help people living with dementia, without making assumptions.”

The first launch for D-Esc to the aged care sector was in Sydney on Thursday 23 May, followed by a launch in Adelaide on Wednesday 29 May, and in Melbourne today on Thursday 6 June, Melbourne Convention and Exhibition Centre, 10:00 – 11:30am where guests can experience demonstrations.

The D-Esc workshops are designed for frontline health and aged care workers across residential, home and community care, primary and acute care and disability care. Workshop delivery is an in person 3-hour workshop, with up to 15 participants.

D-Esc is a fully funded workshop until 30 June 2025, available to 6,500 eligible participants. To confirm the eligibility of your staff please visit dementia.org.au/d-esc or contact development@dementia.org.au.

D-Esc was developed with the Applied Artificial Intelligence Institute (A²I²), Deakin University.

D-Esc is a Dementia Australia program created with support from The Rosemary Norman Foundation, Fitzpatrick Sykes Family Foundation, Navarra Care Foundation and Australian Communities Foundation through HDR Australia Fund. With the support of Dementia Training Australia and the Australian Government, the D-Esc workshop is free for 6,500 eligible participants until 30 June 2025.

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

-Ends-

Media contacts:

Gabrielle Prabhu, Media & Communications Manager, Gabrielle.Prabhu@dementia.org.au, 0447 253 583

 

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

More from this category

  • Industrial Relations, Medical Health Aged Care
  • 22/06/2024
  • 17:11
Australian Nursing and Midwifery Federation (Victorian Branch)

Nurses and midwives to consider 28.4 per cent wage increase

SATURDAY 22 JUNE 2024 The Australian Nursing and Midwifery Federation (Victoria Branch) has called a statewide meeting of members to consider the Allan Government’s offer of a 28.4 per cent (compounded) wage increase by the end of the fourth year. The offer is an in-principle agreement subject to both cabinet approval and member endorsement. It follows intensive discussions between the ANMF and senior representatives from the Department of Health and the Allan Government and 48 days of protected industrial action which began on Tuesday 7 May. ANMF members will meet on Wednesday 26 June in Melbourne and eight satellite venues…

  • Contains:
  • Medical Health Aged Care
  • 22/06/2024
  • 06:08
Takeda Pharmaceutical Company Limited

Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer

− Approval Based on Results from Positive, Global, Phase 3 FRESCO-2 Trial − FRUZAQLA (fruquintinib) is the First Novel Targeted Therapy in the EU…

  • Contains:
  • Medical Health Aged Care
  • 21/06/2024
  • 16:08
Kolmar BNH

Kolmar BNH Sharpens Global Competitiveness with Dual Functionality of HemoHIM

SEOUL, South Korea–BUSINESS WIRE– Kolmar BNH (KOSDAQ: 200130), a leading Original Development Manufacturing (ODM) company for health functional foods, strengthens its market position by…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.